newsfilter
← Latest News
ClinicalTrials.gov·

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF - NCT04945460

Change in Pulmonary Vascular Resistance (PVR) at 24 weeks from baseline, Change in 6MWD (6 minute walk distance), Number of Clinical Worsening events., (and 31 more...)